EBM Technologies Incorporated (TPEX:8409)
20.70
+0.10 (0.49%)
Apr 2, 2026, 1:30 PM CST
EBM Technologies Revenue
In the year 2025, EBM Technologies had annual revenue of 253.11M TWD, down -9.91%. EBM Technologies had revenue of 82.73M in the quarter ending December 31, 2025, a decrease of -53.53%.
Revenue
253.11M
Revenue Growth
-9.91%
P/S Ratio
2.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
662.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 253.11M | -27.85M | -9.91% |
| Dec 31, 2024 | 280.95M | 74.81M | 36.29% |
| Dec 31, 2023 | 206.15M | -177.74M | -46.30% |
| Dec 31, 2022 | 383.88M | 188.95M | 96.93% |
| Dec 31, 2021 | 194.93M | -20.40M | -9.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| Bora Pharmaceuticals | 19.01B |
| PharmaEssentia | 15.63B |
| Ttbio | 392.72M |
| Sofiva Genomics | 385.71M |
| BioLASCO Taiwan | 262.66M |
| Bioray Biotech | 230.06M |
| Golden Biotechnology | 44.58M |